Kristof Cuppens
@k_cupp_
Followers
490
Following
9K
Statuses
428
MD MSc - Thoracic Oncology, master in hospital and health care management Hasselt - Belgium 🇧🇪 - PhD candidate Amsterdam/Leiden - he/him 🌈
België
Joined November 2014
Extremely proud to announce that our NEOPREDICT-Lung study on neoadjuvant PD-1 and LAG-3 inhibition in resectable NSCLC is now online in @NatureMedicine . Without any doubt one the highlights of my career so far.
5
19
73
RT @StephenVLiu: Phase III EXCLAIM-2 trial of 1L mobocertinib vs chemotherapy in #EGFR exon 20 NSCLC @JCO_ASCO. Negative trial: PFS 9.6m in…
0
31
0
RT @DrSanjayPopat: BIG NEWS. An overall survival improvement is an important justification for treatment intensification. Look forward to s…
0
11
0
0
0
3
RT @MarianaBrandao0: What's the Land of Tomorrow of #IO in #NSCLC? At #ESMOImmune2024 I had the honor to discuss the data on 🔴 PDC*lung01 v…
0
9
0
@JackWestMD We “constructed” a similar chart on nodal evolution in our NEOPredictLung study for WCLC2024 as well. Nerve wrecking to make but very informative and gets the message across
1
0
0
Excited to announce I joined the Staging and Prognostic Factors Committee of the @IASLC ! Looking forward to collaborating with global experts and honored to contribute to the ongoing efforts in defining the future of lung cancer care. #LungCancer #IASLC #CancerResearch #GlobalHealth #tnm10 @LCRCenter @BIOMED_UHasselt @JessaWetenschap @JessaZiekenhuis
0
0
1
The Adenosinergic Pathway in Non-Small Cell Lung Cancer. #mdpicancers via @Cancers_MDPI @JessaWetenschap @BIOMED_UHasselt @LCRCenter @JessaZiekenhuis
0
0
4
RT @jillfeldman4: The grading system ONLY captures safety! The grading system DOES NOT capture IMPACT! The grading system DOES NOT capture…
0
17
0
I had the honour to present updated analysis of our NEOPREDICT-Lung study at #WCLC24 . Exciting data on nodal clearance by combining PD-1 and LAG-3 inhibition! Excellent session chaired by @DoctorJSpicer and prof. Senan. Great discussion by prof. Cascone. @JessaZiekenhuis @JessaWetenschap @LCRCenter @BIOMED_UHasselt @NKI_nl @UniklinikEssen
2
4
22
Looking forward to seeing everyone there. Hope you can make it! #andreazpneumosymposium
De diensten longziekten van ziekenhuisnetwerk Andreaz nodigen je uit voor een inspirerend symposium waarin we praktijkgerichte vraagstukken zullen bespreken. 📍UHasselt, campus Diepenbeek ℹ️ Inschrijvingen:
0
0
0
RT @FordePatrick: Out now in @JTOonline consensus recommendations from @IASLC on use of neoadjuvant and adjuvant therapy for lung cancer. #…
0
60
0
RT @herbloong: This is an excellent summary! Congrats and thanks for putting this together for the #lungcancer community.
0
1
0
Overwhelmed by all the novel data on immune checkpoint inhibition in early-stage NSCLC? Go check out our omprehensive invited review in @LungCaJournal @myESMO . Another great collaboration between @NKI_nl @JessaZiekenhuis @JessaWetenschap @LCRCenter
0
2
13
RT @jillfeldman4: Just thinking...I strongly advocate changing the dose selection process to a minimal effective dose (balance efficacy wit…
0
16
0
RT @SomersVeerle: Een mooie samenwerking tussen @uhasselt @ZOLziekenhuis en @JessaZiekenhuis rond digitale pathologie in de verdere uit…
0
4
0
Highlighting a new SOC in LS-SCLC: ADRIATIC - Durvalumab post-cCRT @JessaWetenschap @JessaZiekenhuis @LCRCenter
🔥 ASCO 2024 Plenary: Dr @k_cupp_ (Jessa Hospital) discusses the ADRIATIC study results, showing the benefit of consolidation durvalumab following chemoradiotherapy in limited stage small-cell lung cancer, improving progression-free and overall survival.
1
1
3